Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platelet-activating factor levels in term and preterm human milk

M Akisü1, N Kültürsay, N Ozkayin

  • 1Ege University Medical Faculty, Department of Pediatrics, Division of Neonatology, Izmir, Turkey.

Biology of the Neonate
|August 14, 1998
PubMed
Summary

Platelet-activating factor (PAF) levels in human milk were analyzed. Mature milk from mothers delivering full-term infants had higher PAF than preterm infants, but this doesn't fully explain breast milk's protection against necrotizing enterocolitis (NEC).

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A comparison of the femur heads histomorphometrically regarding trabecular bone properties in the patients with osteoporosis and osteoarthritis.

Aging clinical and experimental research·2015
Same author

Improved neonatal prognosis following restriction in the number of transferred embryos in assisted reproduction - single center yearly comparison from Turkey.

Clinical and experimental obstetrics & gynecology·2015
Same author

Genome wide analysis in a discordant monozygotic twin with caudal appendage and multiple congenital anomalies.

Genetic counseling (Geneva, Switzerland)·2013
Same author

Genetic factors that influence short-term neurodevelopmental outcome in term hypoxic-ischaemic encephalopathic neonates.

The Journal of international medical research·2011
Same author

Polycythaemia in infants of diabetic mothers: β-hydroxybutyrate stimulates erythropoietic activity.

The Journal of international medical research·2011
Same author

[MEFV gene mutation spectrum in familial Mediterranean fever (FMF) : a single center study in the Aegean region of Turkey].

Zeitschrift fur Rheumatologie·2011

Area of Science:

  • Neonatal Medicine
  • Biochemistry
  • Immunology

Background:

  • Necrotizing enterocolitis (NEC) is a serious condition affecting newborns, with lower incidence in breastfed infants.
  • Platelet-activating factor (PAF) is implicated in the pathogenesis of NEC.
  • Human milk composition may influence NEC protection, prompting investigation into its PAF content.

Purpose of the Study:

  • To quantify and compare platelet-activating factor (PAF) levels in human colostrum and mature milk.
  • To investigate potential correlations between maternal gestational age at birth and milk PAF concentrations.
  • To explore the role of milk PAF in the protective effects of human milk against NEC.

Main Methods:

  • Human milk samples (colostrum and mature milk) were collected from three groups of mothers based on gestational age at delivery (<32, 33-37, and >38 weeks).

Related Experiment Videos

  • Platelet-activating factor (PAF) concentrations were measured in all milk samples.
  • Statistical analysis was performed to compare PAF levels across different milk types and maternal groups.

    • Main Results:

    • PAF levels in colostrum were similar across all maternal gestational age groups.
    • Mature milk from mothers delivering full-term infants (>38 weeks) exhibited significantly higher PAF concentrations compared to those delivering preterm infants (<37 weeks).
    • Despite differences in mature milk PAF, the findings do not fully elucidate the protective mechanism of human milk against NEC.

    Conclusions:

    • Maternal gestational age influences PAF concentration in mature human milk.
    • While PAF is present in human milk, its elevated levels in term milk do not solely account for the observed protection against necrotizing enterocolitis.
    • Further research is needed to identify other components or mechanisms responsible for the protective effects of human milk against NEC.